Clinical Trials Directory

Trials / Unknown

UnknownNCT04861389

Distal Transradial Access for Primary Percutaneous Coronary Intervention in STEMI Patients

The Comparison of Distal Transradial Access and Transradial Access for Primary Percutaneous Coronary Intervention in STEMI Patients(RESERVE Trial) A Single-center, Open, Prospective, Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
414 (estimated)
Sponsor
Shenzhen People's Hospital · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The transradial access (TRA) is currently the preferred approach for percutaneous coronary intervention (PCI). However, in patients with ACUTE ST-segment elevation myocardial infarction (STEMI) after emergency PCI, the high incidence of THE radial artery RAO limits the future choice of the radial artery for percutaneous intervention. The literature reported that distal transradial access (dTRA) significantly reduced RAO after elective PCI, but the application of dTRA in emergency PCI in STEMI has not been reported. We have completed 126 cases of dTRA undergoing emergency PCI after STEMI, which has been preliminarily confirmed to be safe and effective. A single-center, open, prospective, randomized controlled study is planned to compare the use of dTRA and TRA in emergency PCI in STEMI patients. The primary endpoint was the INCIDENCE of RAO within 24 hours after surgery. This clinical study verified that dTRA compared with TRA could reduce the RAO incidence of STEMI patients after emergency PCI. The project will explore a new artery approach to reduce RAO, and provide a basis for the selection of artery approach in STEMI emergency PCI patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREArterial accessArterial access for primary percutaneous coronary intervention in STEMI patients

Timeline

Start date
2021-01-01
Primary completion
2021-12-31
Completion
2022-01-31
First posted
2021-04-27
Last updated
2021-04-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04861389. Inclusion in this directory is not an endorsement.